Beta Bionics (BBNX) Receivables (2023 - 2026)

Beta Bionics' Receivables history runs 4 years deep, the most recent figure standing at $15.8 million for Q1 2026.

• In Q1 2026, Receivables rose 73.84% year-over-year to $15.8 million; the TTM figure through Mar 2026 stood at $15.8 million (up 73.84% YoY), while the FY2025 annual figure was $17.3 million, up 44.0% from the prior year.
• Receivables came in at $15.8 million for Q1 2026 at Beta Bionics, down from $17.3 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $17.3 million in Q4 2025 to a low of $4.5 million in Q4 2023.
• A 4-year average of $11.7 million and a median of $11.7 million in 2025 frame the typical range for Receivables.
• Across the five-year window, Receivables jumped 166.93% in 2024 and surged 44.0% in 2025, its largest moves.
• Beta Bionics' Receivables stood at $4.5 million in 2023, then surged by 166.93% to $12.0 million in 2024, then soared by 44.0% to $17.3 million in 2025, then slipped by 8.82% to $15.8 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $15.8 million, $17.3 million, and $11.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison